Is Europe attractive for Life Science Investments?

By Barbara Freischem, Executive Director Last week, I had the privilege of speaking at a roundtable discussion, organised by Johnson&Johnson and EurActiv as part of the European Biotech Week, to address the important question: is Europe attractive for live science investments? Europe certainly has great science and academia; we’re well-regulated and adapting to new challenges; [...]